Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 15;20(1):470.
doi: 10.1186/s12967-022-03687-y.

Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats

Affiliations

Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats

Klaudia M Maksymiuk et al. J Transl Med. .

Abstract

Background: Trimethylamine oxide (TMAO) is a biomarker in cardiovascular and renal diseases. TMAO originates from the oxidation of trimethylamine (TMA), a product of gut microbiota and manufacturing industries-derived pollutant, by flavin monooxygenases (FMOs). The effect of chronic exposure to TMA on cardiovascular and renal systems is undetermined.

Methods: Metabolic, hemodynamic, echocardiographic, biochemical and histopathological evaluations were performed in 12-week-old male SPRD rats receiving water (controls) or TMA (200 or 500 µM/day) in water for 18 weeks. TMA and TMAO levels, the expression of FMOs and renin-angiotensin system (RAS) genes were evaluated in various tissues.

Results: In comparison to controls, rats receiving high dose of TMA had significantly increased arterial systolic blood pressure (126.3 ± 11.4 vs 151.2 ± 19.9 mmHg; P = 0.01), urine protein to creatinine ratio (1.6 (1.5; 2.8) vs 3.4 (3.3; 4.2); P = 0.01), urine KIM-1 levels (2338.3 ± 732.0 vs. 3519.0 ± 953.0 pg/mL; P = 0.01), and hypertrophy of the tunica media of arteries and arterioles (36.61 ± 0.15 vs 45.05 ± 2.90 µm, P = 0.001 and 18.44 ± 0.62 vs 23.79 ± 2.60 µm, P = 0.006; respectively). Mild degeneration of renal bodies with glomerulosclerosis was also observed. There was no significant difference between the three groups in body weight, water-electrolyte balance, echocardiographic parameters and RAS expression. TMA groups had marginally increased 24 h TMA urine excretion, whereas serum levels and 24 h TMAO urine excretion were increased up to 24-fold, and significantly increased TMAO levels in the liver, kidneys and heart. TMA groups had lower FMOs expression in the kidneys.

Conclusions: Chronic exposure to TMA increases blood pressure and increases markers of kidney damage, including proteinuria and KIM-1. TMA is rapidly oxidized to TMAO in rats, which may limit the toxic effects of TMA on other organs.

Keywords: Chronic kidney disease; Hypertension; Kidney damage; Proteinuria; Trimethylamine; Trimethylamine oxide.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1
TMA/TMAO balance. a the amount of TMA consumed per day; b the amount of TMA excreted per day; c the amount of TMAO excreted per day in rats maintained either on tap water (control group) or low and high dose of TMA. TMA, trimethylamine; TMAO, trimethylamine oxide. All data are expressed as the median (n = 9); Kruskal–Wallis test followed by post-hoc Dunn’s test; ***P < 0.001 vs tap water group; ###P < 0.001 vs low dose group
Fig. 2
Fig. 2
Urine biochemical analysis. a protein concentration in urine; b protein to creatinine ratio in urine; c Kim-1 concentration in urine; d glucose concentration in urine in rats maintained either on tap water (control group) or low and high dose of TMA. TMA trimethylamine, UPCR urine protein creatinine ratio. All data are expressed as the median (n = 9); Kruskal–Wallis test followed by post-hoc Dunn’s test for urine protein, UPCR and urine glucose; ANOVA followed by post-hoc Tuckey test for urine Kim-1; *P < 0.05 vs tap water group
Fig. 3
Fig. 3
FMOs genes expression. FMOs in the kidney, liver and lungs. RT-qPCR analysis of FMO1, FMO3 and FMO5 transcript levels in the a renal cortex, b renal medulla, c liver and d lungs in rats maintained either on tap water (control group) or low and high dose of TMA. TMA trimethylamine; FMO Flavin-containing monooxygenase. All data are expressed as the median, Q1, Q3, MIN, MAX (n = 6; use arbitrary units); Kruskal–Wallis test followed by post-hoc Dunn’s test. *P < 0.05 vs tap water group; **P < 0.01 vs tap water group
Fig. 4
Fig. 4
Histopathology of the kidney. a Renal convoluted tubules (original magnification 10X, H&E stain), b renal medium size artery (original magnification 10×, H&E stain), c renal medium size artery (original magnification 40×, H&E stain) in rats maintained either on tap water (control group) or low and high dose of TMA. TMA trimethylamine, L lumen of convoluted renal tubules, Black arrow – vacuoles of various sizes within the cell cytoplasm, White arrow – endothelium
Fig. 5
Fig. 5
Histopathology of the heart. a Myocardium of left ventricle (original magnification 10×, H&E stain), b myocardium of left ventricle (original magnification 40X, H&E stain) in rats maintained either on tap water (control group) or low and high dose of TMA. TMA trimethylamine

Similar articles

Cited by

References

    1. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;20(6):1048–1056. doi: 10.1093/ndt/gfh813. - DOI - PubMed
    1. Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 2008;34(5):957–962. doi: 10.1007/s00134-008-1017-8. - DOI - PubMed
    1. Nanto-Hara F, Kanemitsu Y, Fukuda S, Kikuchi K, Asaji K, Saigusa D, et al. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease. Nephrol Dial Transplant. 2020;35(2):250–264. - PubMed
    1. Zou D, Li Y, Sun G. Attenuation of circulating trimethylamine N-oxide prevents the progression of cardiac and renal dysfunction in a rat model of chronic cardiorenal syndrome. Front Pharmacol. 2021;12:751380. doi: 10.3389/fphar.2021.751380. - DOI - PMC - PubMed
    1. Lekawanvijit S. Role of gut-derived protein-bound uremic toxins in cardiorenal syndrome and potential treatment modalities. Circ J. 2015;79(10):2088–2097. doi: 10.1253/circj.CJ-15-0749. - DOI - PubMed

Publication types